ISPD Board of Directors

2016-2018

President

Ignatia B. Van den Veyver, MD
Houston, Texas, United States

President-Elect

Louise E. Wilkins-Haug, MD, PhD
Boston, Massachusetts, United States

Secretary

Sylvie Langlois, MD, CCMG
Vancouver, British Columbia, Canada

Treasurer

Antoni Borrell, MD, PhD
Barcelona, Catalonia, Spain

Past President

Lucas Otaño, MD, PhD
Buenos, Aires, Argentina

Directors

Rossa W. Chiu, MBBS, PhD, FRCPA
Sha Tin, Hong Kong

Roland Devlieger, MD, PhD
Leuven, Belgium

Monique C. Haak, MD, PhD
Lieden, Netherlands

Sebastian Illanes, MD, MSc
Santiago, Chile

Francesca Romana Grati, PhD
Varese, Italy

R. Douglas Wilson, MD, MSc, FRCSC
Calgary, Alberta, Canada 

Director, Ex-Officio and Editor in Chief, Prenatal Diagnosis
Diana W. Bianchi, MD
Bethesda, Maryland, United States
 

Conflict of Interest

ISPD is committed to full transparency regarding its leadership and the potential for conflicts of interest. Each member of the Board of Directors is required annually to review the Conflict of Interest Policy and disclose, in writing, any potential conflicts. As noted in the policy, if a Director has a conflict of interest relating to any matter under consideration for a decision by the Board of Directors, he or she shall abstain from any vote, discussion (except as the remaining Board deems necessary for informational purposes), or any attempt to influence the decision of the Board on that matter. The Board may also require the Director to be excused from a meeting while the matter is being deliberated and voted. Relevant financial or other relationships exist between the following ISPD Board members and the commercial interests listed below:
Diana W. Bianchi, MD
Declared no conflict of interest
22 March 2018

Antoni Borrell, MD, PhD
Declared no conflict of interest
7 March 2018

Rossa W. Chiu, MBBS, PhD, FRCPA
Founder of Xcelom, Cirina and DRA; Equity in GRAIL and DRA; Consultant for GRAIL; Expert panelist of Illumina; Research funding from GRAIL; Patent royalty income from Illumina, Sequenom, Xcelom, GRAIL and DRA
7 March 2018

Sylvie Langlois, MD, CCMG
I was (2013-2017) co-PI on a Genome Canada funded research project that received in kind co-funding from Quiagen, Life Technologies, Perkin Elmer and AriosaDx. I am currently co-PI on a second Genome Canada Funded research project that will receive in kind co-funding from ThermoFisher. I am receiving research funding (operating funds) for a validation study with BioCeryx.
15 March 2018
Francesca Romana Grati, PhD
Full-time employee of TOMA laboratory without ownership shares; Scientific advisory board member for Roche; Consultant for Menarini Biomarkers
9 March 2018

Ignatia B. Van den Veyver, MD
I am a member of the scientific advisory board of the Baylor-Genetics Laboratories. This is a for profit diagnostic laboratory that is a joint Venture between Baylor college of Medicine and Miraca Holdings. This is a non-compensated position, hence there is no financial conflict of interest.
18 September 2017

Louise E. Wilkins-Haug, MD, PhD
Genetics Section Editor
2 May 2017

R. Douglas Wilson, MD, MSc, FRCSC
Data Safety Monitoring Board GSK; Editorial Board for JOGC / FDT / PD; Co-Chair SOGC Guideline Management Oversite Committee
6 March 2018